One unifying model would be that SARM1 can be activated by more than one mechanism to contribute to sporadic ALS, and that higher levels of SARM1 gene expression make axons more vulnerable to such effects. This evidence concerns the gene SARM1 and amyotrophic lateral sclerosis.